Captrust Financial Advisors Karyopharm Therapeutics Inc. Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$4.15 - $8.37 $601 - $1,213	-145 Reduced 12.66%	1,000 $5,000
Q2 2022 Aug 16, 2022	BUY	$4.15 - $8.37 $601 - $1,213	145 Added 14.5%	1,145 $5,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $651 - $1,076	-125 Reduced 11.11%	1,000 $6,000
Q3 2021 Nov 16, 2021	SELL	$4.45 - $10.63 $14,733 - $35,195	-3,311 Reduced 74.64%	1,125 $7,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $7,590 - $10,398	936 Added 26.74%	4,436 $46,000
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $42,450 - $51,570	3,000 Added 600.0%	3,500 $54,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $8,300 - $12,625	500 New	500 $10,000

59.5M

547K

67K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $336M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.